Atlas Trials

A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery

Clinical trial NCT03809000 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03809000
Sponsor
RTOG Foundation, Inc.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2019-04-15
Primary completion
2023-04-07
Enrollment
188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.